Published in Pharma Law Weekly, January 10th, 2006
Approximately 150 adults with drug-refractory migraine will use DiaryPRO to accurately record the frequency and severity of migraine attacks during this trial. Advanced Bionics will analyze the PRO data collected on DiaryPRO to determine the safety and effectiveness of the Precision neurostimulator among patients with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-01-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.